ArticleFrontiers in pharmacology2022

Case Report: Tackling Complement Hyperactivation With Eculizumab in Atypical Hemolytic Uremic Syndrome Triggered by COVID-19.

Valentina Fanny Leone et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.